3-131469533-TACACACACACACAC-TACACACACACAC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_007208.4(MRPL3):c.816+161_816+162delGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.55 ( 21722 hom., cov: 0)
Consequence
MRPL3
NM_007208.4 intron
NM_007208.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.888
Publications
1 publications found
Genes affected
MRPL3 (HGNC:10379): (mitochondrial ribosomal protein L3) Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein that belongs to the L3P ribosomal protein family. A pseudogene corresponding to this gene is found on chromosome 13q. [provided by RefSeq, Jul 2008]
MRPL3 Gene-Disease associations (from GenCC):
- combined oxidative phosphorylation defect type 9Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
new If you want to explore the variant's impact on the transcript NM_007208.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 3-131469533-TAC-T is Benign according to our data. Variant chr3-131469533-TAC-T is described in ClinVar as Benign. ClinVar VariationId is 1259936.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.621 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_007208.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MRPL3 | TSL:1 MANE Select | c.816+161_816+162delGT | intron | N/A | ENSP00000264995.2 | P09001 | |||
| MRPL3 | TSL:2 | c.897+161_897+162delGT | intron | N/A | ENSP00000398536.2 | E7ETU7 | |||
| MRPL3 | TSL:2 | c.858+161_858+162delGT | intron | N/A | ENSP00000424107.1 | H0Y9G6 |
Frequencies
GnomAD3 genomes AF: 0.549 AC: 80316AN: 146404Hom.: 21713 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
80316
AN:
146404
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.549 AC: 80368AN: 146514Hom.: 21722 Cov.: 0 AF XY: 0.543 AC XY: 38779AN XY: 71420 show subpopulations
GnomAD4 genome
AF:
AC:
80368
AN:
146514
Hom.:
Cov.:
0
AF XY:
AC XY:
38779
AN XY:
71420
show subpopulations
African (AFR)
AF:
AC:
25113
AN:
40006
American (AMR)
AF:
AC:
8119
AN:
14678
Ashkenazi Jewish (ASJ)
AF:
AC:
1682
AN:
3392
East Asian (EAS)
AF:
AC:
1629
AN:
4766
South Asian (SAS)
AF:
AC:
1930
AN:
4614
European-Finnish (FIN)
AF:
AC:
4969
AN:
9806
Middle Eastern (MID)
AF:
AC:
159
AN:
280
European-Non Finnish (NFE)
AF:
AC:
35190
AN:
66094
Other (OTH)
AF:
AC:
1103
AN:
1986
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1730
3460
5191
6921
8651
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.